ArticleProceedings of the National Academy of Sciences of the United States of America2013

Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.

Daisuke Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.